Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gabriella R. Marriott"'
Autor:
Sean P. Kennedy, Jeremy Z. R. Han, Neil Portman, Max Nobis, Jordan F. Hastings, Kendelle J. Murphy, Sharissa L. Latham, Antonia L. Cadell, Dushan Miladinovic, Gabriella R. Marriott, Yolande E. I. O’Donnell, Robert F. Shearer, James T. Williams, Amaya Garcia Munoz, Thomas R. Cox, D. Neil Watkins, Darren N. Saunders, Paul Timpson, Elgene Lim, Walter Kolch, David R. Croucher
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-17 (2019)
Abstract Background The oncogenic receptor tyrosine kinase (RTK) ERBB2 is known to dimerize with other EGFR family members, particularly ERBB3, through which it potently activates PI3K signalling. Antibody-mediated inhibition of this ERBB2/ERBB3/PI3K
Externí odkaz:
https://doaj.org/article/63c93a219e074dd1a11996f46df83abd
Autor:
Frances L. Byrne, Ellen M. Olzomer, Gabriella R. Marriott, Lake-Ee Quek, Alice Katen, Jacky Su, Marin E. Nelson, Gene Hart-Smith, Mark Larance, Veronica F. Sebesfi, Jeff Cuff, Gabriella E. Martyn, Elizabeth Childress, Stephanie J. Alexopoulos, Ivan K. Poon, Maree C. Faux, Antony W. Burgess, Glen Reid, Joshua A. McCarroll, Webster L. Santos, Kate GR. Quinlan, Nigel Turner, Daniel J. Fazakerley, Naresh Kumar, Kyle L. Hoehn
Publikováno v:
Redox Biology, Vol 28, Iss , Pp - (2020)
A hallmark of cancer cells is their ability to reprogram nutrient metabolism. Thus, disruption to this phenotype is a potential avenue for anti-cancer therapy. Herein we used a phenotypic chemical library screening approach to identify molecules that
Externí odkaz:
https://doaj.org/article/5e4c5baf666144d5a43fe60f14c4e6fb
Autor:
Max Nobis, Robert F. Shearer, Paul Timpson, Amaya Garcia Munoz, Darren N. Saunders, Kendelle J. Murphy, Neil Portman, D. Neil Watkins, Jordan F. Hastings, Thomas R. Cox, David R. Croucher, James T. Williams, Walter Kolch, Gabriella R. Marriott, Antonia L Cadell, Sharissa L. Latham, Jeremy Z. R. Han, Yolande E. I. O’Donnell, Elgene Lim, Sean P. Kennedy, Dushan Miladinovic
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 21, Iss 1, Pp 1-17 (2019)
Breast Cancer Research, Vol 21, Iss 1, Pp 1-17 (2019)
Background The oncogenic receptor tyrosine kinase (RTK) ERBB2 is known to dimerize with other EGFR family members, particularly ERBB3, through which it potently activates PI3K signalling. Antibody-mediated inhibition of this ERBB2/ERBB3/PI3K axis has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b89b30d561873fa9e54ee4aacf7cd73
https://doi.org/10.1186/s13058-019-1127-y
https://doi.org/10.1186/s13058-019-1127-y